RxDoctor Payments Data

Jessica Belmonte, MD

Hematology & Oncology · Albuquerque, NMNPI 1346566437

Payments from drug & device makers

What this record shows

That places this record below the midpoint for hematology & oncology clinicians in NM, where the typical reported total is $2,649.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$137,634in research payments, 2019–2025

Across 9 payments — averaging $15,293 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$63K
  • Beigene, Ltd.$43K
  • Beone Medicines USA, Inc.$18K
  • Macrogenics, Inc.$14K
  • Amgen$322

How this compares

$0 in reported general payments places this provider in the 0th percentile of 54 hematology & oncology providers in New Mexico.

See all hematology & oncology providers in New Mexico

Medicare billing

Part B allowed, 2024
$13,503
Medicare patients
69
Services billed
188

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fentanyl11$1,057
Oxycodone Hcl40$911
Prochlorperazine Maleate16$173
Ondansetron Hcl18$155
Famotidine11$97

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →